Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm

Coronary Artery Disease

Volumn 18, Issue 2, 2007, Pages 83-87

  Cho, Dae Kyoung ^a   Choi, Jin Oh ^b,c   Kim, Sung Hea ^b   Choi, Jinoh ^b   Rhee, Il ^b   Ki, Chang Seok ^b   Lee, Sang Chol ^b   Gwon, Hyeon Cheol ^b  

^a Hanmaeum Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c NONE   (South Korea)

Author keywords

Coronary vasospasm; Ischemia modified albumin; Myocardial ischemia; Variant angina

Indexed keywords

BIOCHEMICAL MARKER; ERGOMETRINE; HUMAN SERUM ALBUMIN;

ADULT; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY SPASM; DISEASE MARKER; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CORONARY VASOSPASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN;

EID: 33847020819     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328010a49f     Document Type: Article

References (24)

1. Chan B, Dodsworth N, Woodrow J, Tucker A, Harris R. Site-specific N-terminal auto-degradation of human serum albumin. Eur J Biochem 1995; 227:524-528.
2. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. J Emerg Med 2000; 19:311-315.
3. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001; 141:985-991.
4. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2 + ) and Ni(2 + ) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268:42-47.
5. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001; 47:464-470.
6. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003; 49:581-585.
7. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004; 50:1656-1660.
8. Abadie JM, Blassingame CL, Bankson DD. Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 2005; 35:66-72.
9. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003; 92:322-324.
10. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107:2403-2405.
11. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 2004; 93:88-90.
12. Aikawa K, Saitoh S, Muto M, Osugi T, Matsumoto K, Onogi F, et al. Effects of antioxidants on coronary microvascular spasm induced by epicardial coronary artery endothelial injury in pigs. Coronary Artery Dis 2004; 15:21-30.
13. Miyamoto S, Kawano H, Sakamoto T, Soejima H, Kajiwara I, Hokamaki J, et al. Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxidant Redox Signal 2004; 6:75-80.
14. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004; 50:2190-2193.
15. Refaai MA, Wright RW, Parvin CA, Gronowski AM, Scott MG, Eby CS. Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta 2006; 366:264-268.
16. Zapico-Muniz E, Santalo-Bel M, Merce-Muntanola J, Montiel JA, Martinez-Rubio A, Ordonez-Llanos J. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 2004; 50:1063-1065.
17. Lee KJ, Lee SH, Hong KP, Park JE, Seo JD, Gwon HC. Feasibility and safety of the transradial approach for the intracoronary spasm provocation test. Catheter Cardiovasc Interv 2005; 65:240-246.
18. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 2003; 26:177-181.
19. Morita Y, Takahashi H, Kamihata H, Yamamoto Y, Hara K, Iwasaka T. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina. Int J Cardiol 2001; 80:243-250.
20. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of 'Ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21:29-34.
21. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004; 97:297-301.
22. Anwaruddin S, Januzzi JL Jr, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005; 123:140-145.
23. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002; 48:1097-1100.
24. van der Zee PM, Verberne HJ, van Straalen JP, Sanders GT, Van Eck-Smit BL, de Winter RJ, Fischer JC. Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 2005; 51:1744-1746.